Born in 1941, Dr. Soskolne graduated from the Dental School of the University of the Witwatersrand, South Africa, in 1965. He proceeded to England, where he was awarded a PhD from the University of London in 1971 for research in periodontics and oral pathology. He has made significant contributions to scientific literature in the fields of oral pathology, bone physiology, and the pathogenesis of periodontal diseases. Among his publications is a series of landmark studies on the ultrastructure of peripheral giant cell granulomas and the first evidence of the role of osteoblasts in what later became known as apoptosis of osteocytes. Based on experimental models used during collaboration with Drs. Nuki and Raisz, Dr. Soskolne developed an organ-culture model, for the study of bone remodeling, which has been used extensively to study bone physiology and the modulation of bone modeling by sex hormones for the purpose of understanding the role of sex hormones in bone pathology.
Dr. Soskolne was also a part of the team that developed the first biodegradable sustained-release delivery system for the treatment of periodontal disease, with Drs. Friedman and Sela. These studies have resulted in the development of a therapeutic devicethe PerioChip. Dr. Soskolne has been active in the development of dental science in Israel and was one of the founding members of the Israeli Division of the IADR and served as its President. He has also been active in the IADR and the Periodontal Research Group of the IADR for many years and has been directly involved in stimulating and developing
Contact: Linda Hemphill
International & American Association for Dental Research